Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 6, Number 5—October 2000

Research

Atypical Chryseobacterium meningosepticum and Meningitis and Sepsis in Newborns and the Immunocompromised, Taiwan

Cheng-Hsun Chiu*Comments to Author , Michael Waddingdon†, Wu-Shiun Hsieh*, David Greenberg‡, Paul C. Schreckenberger§, and Amy M. Carnahan¶
Author affiliations: *Chang Gung Children's Hospital, Taoyuan, Taiwan; †Accugenix, Inc., Newark, Delaware; ‡British Columbia's Children's Hospital, Vancouver, British Columbia, Canada; §University of Illinois at Chicago Medical Center, Chicago, Illinois, USA; ¶University of Maryland School of Medicine, Baltimore, Maryland, USA

Main Article

Table 2

Comparative in vitro activity of various antibiotics against 17 strains of atypical Chryseobacterium meningosepticum

MIC (µg/mL)
Antibiotics Range MIC50 MIC90
Ampicillin 16-64 32 32
Ticarcillin 32->128 128 >128
Piperacillin 1-128 8 32
Cephalothin 32->32 32 32
Cefamandole 16->32 >32 >32
Cefotaxime 8->32 32 >32
Ceftriaxone 8->32 16 32
Imipenem 1->32 32 32
Ceftazidime 2-64 16 >32
Gentamicin 16-64 32 64
Amikacin 2-64 64 64
Ciprofloxacin 0.25-16 1 4

Main Article

TOP